Barts (London) and Brighton
Barts and Brighton ECMC bring together two sites with complementary skills to create a centre of excellence that will facilitate the translation of basic scientific discovery into the delivery of novel treatments to patients with cancer. Specifically, this joint Centre will build upon the strengths of the existing basic and translational science units within Barts Cancer Institute and Brighton and Sussex Cancer Research Centre.
Clinical Focus Area
- Haemato-oncology
- Thoracic malignancies
- Women’s cancers
- Hepatobiliary cancers
- Urological cancers
- Cancer imaging
Scientific Focus Area
- Cancer and inflammation
- Angiogenesis
- DNA damage signalling
- Cancer cell signalling and metabolism
- Complex biological therapies
- Cancer imaging
Disease focus
| Bladder | Breast | Kidney | Leukaemia |
| Liver | Lymphoma | Myeloma | Ovarian |
| Pancreatic | Prostate | All advanced cancers |
Goals
Skills
Barts ECMC principal investigators and staff have a diverse range of skills and expertise.
Facilities
Barts ECMC has access to a range of research facilities that are utilised in studies.
Increase text
Decrease text
Print this page